UP!

NMR $5.73

NMR target price
5.73
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2021 2022-08-03 0.00 0.00
Q4 2020 2022-04-26 0.00 0.00
Q3 2020 2022-02-01 0.00 0.00
Q2 2020 2021-10-29 0.00 0.00
Q1 2020 2021-07-30 0.00 0.00
Q4 2019 2021-04-27 0.00 0.00
Q3 2019 2020-01-30 0.00 0.17
Q2 2019 2019-10-29 0.00 0.38
Q1 2019 2019-07-31 0.00 0.15
Q4 2018 2019-04-25 0.00 0.01

Ratings

2016-07-08 Downgrade Morgan Stanley Overweight to Equal
2016-06-27 Downgrade Daiwa Capital Markets Outperform to Neutral
2016-06-24 Downgrade JPMorgan Chase & Co. Neutral to Underweight
2016-06-24 Downgrade Jefferies Group Outperform to Neutral
2016-02-22 Downgrade Goldman Sachs Neutral to Sell
2016-02-22 Downgrade Goldman Sachs Group Inc. Neutral to Sell
2016-02-10 Downgrade Credit Suisse Outperform to Neutral
2016-02-10 Downgrade Credit Suisse Group AG Outperform to Neutral
2016-02-08 Downgrade Deutsche Bank Buy to Hold
2016-02-08 Downgrade Jefferies Buy to Hold
2016-02-08 Downgrade Jefferies Group Buy to Hold
2016-02-08 Downgrade Deutsche Bank AG Buy to Hold
2015-07-07 Upgrade Barclays Underperform to Equal Weight
2015-07-07 Upgrade Barclays PLC Underperform to Equal Weight
2015-06-23 Upgrade Barclays Underperform to Equal Weight
2014-11-07 Downgrade Macquarie Outperform to Neutral
2014-10-23 Upgrade Macquarie Neutral to Outperform
2014-08-25 Upgrade Credit Suisse Neutral to Outperform
2014-07-10 Downgrade Macquarie Outperform to Neutral
2014-05-14 Downgrade Credit Suisse Outperform to Neutral
2012-09-04 Upgrade Macquarie Underperform to Neutral
2016-07-08 Downgrade Morgan Stanley Overweight to Equal
2016-06-27 Downgrade Daiwa Capital Markets Outperform to Neutral
2016-06-24 Downgrade JPMorgan Chase & Co. Neutral to Underweight
2016-06-24 Downgrade Jefferies Group Outperform to Neutral
2016-02-22 Downgrade Goldman Sachs Neutral to Sell

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks